A Phase 2 Randomized, Controlled, Open-label (Dose-blinded), Multi-center, Dose-finding Study of the Safety and Efficacy of I-0401 in the Treatment of Patients With Fractures of the Tibial Plateau Requiring Grafting.

Trial Profile

A Phase 2 Randomized, Controlled, Open-label (Dose-blinded), Multi-center, Dose-finding Study of the Safety and Efficacy of I-0401 in the Treatment of Patients With Fractures of the Tibial Plateau Requiring Grafting.

Completed
Phase of Trial: Phase II

Latest Information Update: 23 Nov 2016

At a glance

  • Drugs KUR-111 (Primary)
  • Indications Fracture
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 Oct 2015 Results from this trial presented at the 2015 Orthopaedic Trauma Association Annual Meeting, according to a Kuros Biotechnology media release.
    • 09 Oct 2015 Results published in a Kuros Biosurgery media release.
    • 29 Jun 2012 New source identified and integrated: European Clinical Trials Database record EudraCT2006-003688-30.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top